MIGUEL ANGEL
SERRA DESFILIS
CATEDRÁTICO/A DE UNIVERSIDAD
Hospital Clinic Barcelona
Barcelona, EspañaHospital Clinic Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2024
-
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
Journal of Hepatology, Vol. 81, Núm. 6, pp. 930-940
2023
-
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Gastroenterologia y Hepatologia, Vol. 46, Núm. 8, pp. 594-602
2021
-
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium
Journal of Hepatology, Vol. 74, Núm. 1, pp. 200-219
2017
-
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection
Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237
2015
-
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program
Journal of Viral Hepatitis, Vol. 22, Núm. 5, pp. 469-480